These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
25. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values. Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016 [TBL] [Abstract][Full Text] [Related]
26. Biodistribution of [(68)Ga]PSMA-HBED-CC in Patients with Prostate Cancer: Characterization of Uptake in Normal Organs and Tumour Lesions. Prasad V; Steffen IG; Diederichs G; Makowski MR; Wust P; Brenner W Mol Imaging Biol; 2016 Jun; 18(3):428-36. PubMed ID: 27038316 [TBL] [Abstract][Full Text] [Related]
27. Relationships between serum PSA levels, Gleason scores and results of 68Ga-PSMAPET/CT in patients with recurrent prostate cancer. Sanli Y; Kuyumcu S; Sanli O; Buyukkaya F; İribaş A; Alcin G; Darendeliler E; Ozluk Y; Yildiz SO; Turkmen C Ann Nucl Med; 2017 Nov; 31(9):709-717. PubMed ID: 28900854 [TBL] [Abstract][Full Text] [Related]
29. Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit. Maestroni UV; Campobasso D; Guarino G; Acampora A; Scarlattei M; Ziglioli F; Dinale F; Baldari G; Migliari S; Gasparro D; Ferretti S; Silini EM; Ruffini L Chin Clin Oncol; 2023 Jun; 12(3):22. PubMed ID: 37417288 [TBL] [Abstract][Full Text] [Related]
30. Correlations of the Karyagar SS; Karyagar S; Guven O Hell J Nucl Med; 2020; 23(2):120-124. PubMed ID: 32716402 [TBL] [Abstract][Full Text] [Related]
31. Predictive significance of intraprostatic volumetric parameters derived from early and standard time 68Ga-PSMA PET/CT images in newly diagnosed prostate cancer patients. Erdogan EB; Tekce E; Koca S; Aslan N; Toluk O; Aydin M Nucl Med Commun; 2024 Jul; 45(7):629-641. PubMed ID: 38835183 [TBL] [Abstract][Full Text] [Related]
32. Role of baseline Telli TA; Ozguven S; Alan O; Filizoglu N; Ozturk MA; Sariyar N; Isik S; Arikan R; Demircan NC; Basoglu T; Cetin IA; Ones T; Ercelep O; Dane F; Yumuk PF Ann Nucl Med; 2022 Nov; 36(11):964-975. PubMed ID: 35997890 [TBL] [Abstract][Full Text] [Related]
33. The role of Ga Erdogan M; Sengul SS; Cetin B; Avcı M; Yagci S; Ozkoç I; Barikan DE; Yildiz M Ann Nucl Med; 2022 Jun; 36(6):562-569. PubMed ID: 35397091 [TBL] [Abstract][Full Text] [Related]
34. Schmidkonz C; Cordes M; Schmidt D; Bäuerle T; Goetz TI; Beck M; Prante O; Cavallaro A; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1862-1872. PubMed ID: 29725716 [TBL] [Abstract][Full Text] [Related]
35. Ga-PSMA PET/CT Staging of Newly Diagnosed Intermediate- and High-Risk Prostate Cancer. Kuten J; Mabjeesh NJ; Lerman H; Levine C; Barnes S; Even-Sapir E Isr Med Assoc J; 2019 Feb; 21(2):100-104. PubMed ID: 30772960 [TBL] [Abstract][Full Text] [Related]
36. Primary Staging of Prostate Cancer Patients with [ Hoffmann MA; Müller-Hübenthal J; Rosar F; Fischer N; von Eyben FE; Buchholz HG; Wieler HJ; Schreckenberger M J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078994 [TBL] [Abstract][Full Text] [Related]
37. Semi-automatic evaluation of baseline whole-body tumor burden as an imaging biomarker of Zou Q; Jiao J; Zou MH; Li MZ; Yang T; Xu L; Zhang Y Abdom Radiol (NY); 2020 Dec; 45(12):4202-4213. PubMed ID: 32948911 [TBL] [Abstract][Full Text] [Related]
38. Liu C; Liu T; Zhang N; Liu Y; Li N; Du P; Yang Y; Liu M; Gong K; Yang X; Zhu H; Yan K; Yang Z Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1852-1861. PubMed ID: 29717333 [TBL] [Abstract][Full Text] [Related]
39. The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer. Luining WI; Hagens MJ; Meijer D; Ringia JB; de Weijer T; Bektas HO; Ettema RH; Knol RJJ; Roeleveld TA; Srbljin S; Weltings S; Koppes JCC; van Moorselaar RJA; van Leeuwen PJ; Oprea-Lager DE; Vis AN Eur Urol Open Sci; 2024 Jan; 59():55-62. PubMed ID: 38298765 [TBL] [Abstract][Full Text] [Related]